| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ONCOLYTICS BIOTECH INC | Director | Common Shares | 492,414 | $415,892 | $0.8446 | 12 Feb 2026 | Direct |
| Altimmune, Inc. | Director | Common Stock, par value $0.0001 | 13,498 | $55,098 | $4.08 | 08 Jan 2026 | Direct |
| Altimmune, Inc. | Director | Stock Options (option to buy) | 48,800 | 25 Sep 2025 | Direct | ||
| Provention Bio, Inc. | Director | Common Stock | 0 | $24.32 | 27 Apr 2023 | Direct | |
| Provention Bio, Inc. | Director | Option to Purchase Common Stock | 0 | 27 Apr 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ONCY | ONCOLYTICS BIOTECH INC | 12 Feb 2026 | 1 | +$25,338 | 4 | Director | 13 Feb 2026, 07:00 |
| ALT | Altimmune, Inc. | 08 Jan 2026 | 1 | +$20,410 | 4 | Director | 09 Jan 2026, 16:10 |
| ONCY | ONCOLYTICS BIOTECH INC | 01 Jan 2026 | 0 | $0 | 3 | Director | 02 Jan 2026, 16:30 |
| ALT | Altimmune, Inc. | 25 Sep 2025 | 1 | $0 | 4 | Director | 29 Sep 2025, 16:12 |
| ALT | Altimmune, Inc. | 26 Sep 2024 | 1 | $0 | 4 | Director | 30 Sep 2024, 18:36 |
| ALT | Altimmune, Inc. | 28 Sep 2023 | 1 | $0 | 4 | Director | 29 Sep 2023, 17:00 |
| /report/000149315223013919-pisano-wayne-2023-04-27 | Provention Bio, Inc. | 27 Apr 2023 | 6 | $0 | 4 | Director | 27 Apr 2023, 18:07 |
| ALT | Altimmune, Inc. | 22 Dec 2022 | 3 | -$248,268 | 4 | Director | 22 Dec 2022, 15:05 |
| ALT | Altimmune, Inc. | 29 Sep 2022 | 1 | $0 | 4 | Director | 30 Sep 2022, 21:22 |
| /report/000149315222014371-pisano-wayne-2022-05-17 | Provention Bio, Inc. | 17 May 2022 | 1 | $0 | 4 | Director | 18 May 2022, 18:06 |
| ALT | Altimmune, Inc. | 23 Sep 2021 | 1 | $0 | 4 | Director | 24 Sep 2021, 20:46 |
| /report/000149315221011597-pisano-wayne-2021-05-12 | Provention Bio, Inc. | 12 May 2021 | 1 | $0 | 4 | Director | 14 May 2021, 19:55 |